Regulations.gov document
Attachment 3 - Proposed Labeling: Testosterone Enanthate Injection, USP 400 mg/2 mL (200…
Supporting & Related Material · FDA-2025-P-1085 · posted Apr 15, 2025
Key facts
| Document ID | FDA-2025-P-1085-0005 |
|---|---|
| Title | Attachment 3 - Proposed Labeling: Testosterone Enanthate Injection, USP 400 mg/2 mL (200 mg/mL) pre-filled syringe |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2025-P-1085 |
| Posted | Apr 15, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: